Linked Life Data

20023535

Source:http://linkedlifedata.com/resource/pubmed/id/20023535

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20023535rdf:typepubmed:Citationlld:pubmed
pubmed-article:20023535lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C0038525lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:20023535lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:20023535pubmed:issue1lld:pubmed
pubmed-article:20023535pubmed:dateCreated2009-12-21lld:pubmed
pubmed-article:20023535pubmed:abstractTextHypertensive hypervolemic therapy is widely used to treat symptomatic vasospasm after subarachnoid hemorrhage. Few data exist to support a relationship between early clinical response and mortality or functional outcome.lld:pubmed
pubmed-article:20023535pubmed:languageenglld:pubmed
pubmed-article:20023535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20023535pubmed:citationSubsetIMlld:pubmed
pubmed-article:20023535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20023535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20023535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20023535pubmed:statusMEDLINElld:pubmed
pubmed-article:20023535pubmed:monthJanlld:pubmed
pubmed-article:20023535pubmed:issn1524-4040lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:ConnollyE...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:ClaassenJanJlld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:MayerStephan...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:BadjatiaNeera...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:WartenbergKat...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:FronteraJenni...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:FernandezAndr...lld:pubmed
pubmed-article:20023535pubmed:authorpubmed-author:SchmidtJ...lld:pubmed
pubmed-article:20023535pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20023535pubmed:volume66lld:pubmed
pubmed-article:20023535pubmed:ownerNLMlld:pubmed
pubmed-article:20023535pubmed:authorsCompleteYlld:pubmed
pubmed-article:20023535pubmed:pagination35-41; discussion 41lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:meshHeadingpubmed-meshheading:20023535...lld:pubmed
pubmed-article:20023535pubmed:year2010lld:pubmed
pubmed-article:20023535pubmed:articleTitleClinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage.lld:pubmed
pubmed-article:20023535pubmed:affiliationDepartments of Neurosurgery and Neurology, Neuroscience Intensive Care Unit, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1136, New York, NY 10029, USA. Jennifer.Frontera@mountsinai.orglld:pubmed
pubmed-article:20023535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20023535pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:20023535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed